BRPI9911178C1 - derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos - Google Patents
derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmosInfo
- Publication number
- BRPI9911178C1 BRPI9911178C1 BRPI9911178A BRPI9911178A BRPI9911178C1 BR PI9911178 C1 BRPI9911178 C1 BR PI9911178C1 BR PI9911178 A BRPI9911178 A BR PI9911178A BR PI9911178 A BRPI9911178 A BR PI9911178A BR PI9911178 C1 BRPI9911178 C1 BR PI9911178C1
- Authority
- BR
- Brazil
- Prior art keywords
- ocor
- hydrogen
- compounds
- cooch
- bipyrrolidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/48—Methylene radicals, substituted by hetero rings
- C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
patente de invenção:<b>"derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems"<d>. a presente invenção refere-se a novos compostos de fórmula (i) em que r^ 1^ é hidrogênio, c~ 1-6~-alquila, opcionalmente substituída por flúor, ou c~ 3-6~-cicloalquila; r^ 2^ é hidrogênio ou um grupo selecionado de -ch~ 2~c(=chr)-coor, -ch~ 2~ocor, -ch(r)ocor, -ch(r)ocoor, -ch(ocor)ocor, -cr~ 2~coch~ 2~ocor e (ii); r^ 3^ é hidrogênio ou grupo selecionado de -ch~ 2~c(=ch~ 2~)-coor, -cooch~ 2~c(=chr)-coor, -cooch~ 2~ocor, -cooch(r)ocor, -cooch(r)ocoor, -cooch(ocor)ocor, -cooch~ 2~coch~ 2~ocor, e (iii); com a condição de que um de r^ 2^ e r^ 3^ seja hidrogênio e o outro de r^ 2^ e r^ 3^ seja diferente de hidrogênio, r é hidrogênio ou c~ 1-6~-alquila; r^ 4^ é hidrogênio ou hidróxi, r^ 5^é hidrogênio ou <sym>-hidroxialquila; e x é ch ou n, assim como a sais farmaceuticamente aceitáveis dos referidos compostos e hidratos dos referidos compostos e de seus sais, e ao uso de compostos de fórmula (i) e de sais farmaceuticamente aceitáveis dos referidos compostos e hidratos dos referidos compostos e de seus sais para a fabricação de preparações farmacêuticas contendo tais compostos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98110888 | 1998-06-15 | ||
| EP98117099 | 1998-09-10 | ||
| PCT/EP1999/003907 WO1999065920A1 (en) | 1998-06-15 | 1999-06-07 | Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI9911178C1 true BRPI9911178C1 (pt) | 2021-05-25 |
Family
ID=26149347
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9911178A BRPI9911178B8 (pt) | 1998-06-15 | 1999-06-07 | derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos |
| BRPI9911178A BRPI9911178C1 (pt) | 1998-06-15 | 1999-06-07 | derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9911178A BRPI9911178B8 (pt) | 1998-06-15 | 1999-06-07 | derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1087980B1 (pt) |
| JP (1) | JP3872955B2 (pt) |
| KR (1) | KR100411915B1 (pt) |
| CN (1) | CN1136222C (pt) |
| AR (1) | AR018675A1 (pt) |
| AT (1) | ATE231871T1 (pt) |
| AU (1) | AU754732B2 (pt) |
| BE (1) | BE2014C034I2 (pt) |
| BR (2) | BRPI9911178B8 (pt) |
| CA (1) | CA2334568C (pt) |
| CO (1) | CO5080758A1 (pt) |
| DE (1) | DE69905162T2 (pt) |
| DK (1) | DK1087980T3 (pt) |
| ES (1) | ES2190222T3 (pt) |
| FR (1) | FR14C0044I2 (pt) |
| GT (1) | GT199900084A (pt) |
| HU (1) | HUP0105426A3 (pt) |
| ID (1) | ID27686A (pt) |
| IL (1) | IL139872A0 (pt) |
| LU (1) | LU92564I2 (pt) |
| MA (1) | MA26650A1 (pt) |
| NO (1) | NO20006350L (pt) |
| PA (1) | PA8475701A1 (pt) |
| PE (1) | PE20000645A1 (pt) |
| PL (1) | PL344994A1 (pt) |
| SV (1) | SV1999000075A (pt) |
| TN (1) | TNSN99114A1 (pt) |
| WO (1) | WO1999065920A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6267100A (en) * | 1999-07-07 | 2001-01-30 | F. Hoffmann-La Roche Ag | Vinylpyrrolidinone derivatives with substituted thiazole ring |
| DE60123513T2 (de) | 2000-04-19 | 2007-05-10 | Basilea Pharmaceutica Ag | Verfahren zur Herstellung von D-Asparaginderivaten |
| US6504025B2 (en) | 2000-05-24 | 2003-01-07 | Basilea Pharmaceutica Ag | Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives |
| DK1606293T3 (da) * | 2003-03-27 | 2009-10-05 | Basilea Pharmaceutica Ag | Cephalosporin i krystallinsk form |
| EP1656930A1 (en) * | 2004-11-10 | 2006-05-17 | Basilea Pharmaceutica AG | Stabilized freeze-dried formulation for cephalosporin derivatives |
| AR071318A1 (es) | 2008-04-15 | 2010-06-09 | Basilea Pharmaceutica Ag | Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso |
| WO2010072672A1 (en) | 2008-12-24 | 2010-07-01 | Basilea Pharmaceutica Ag | New crystal polymorphs of ceftobiprole |
| WO2010136423A1 (de) * | 2009-05-25 | 2010-12-02 | Sandoz Ag | Verfahren zur herstellung von ceftobiprol medocaril |
| ES2535822T3 (es) | 2010-05-10 | 2015-05-18 | Basilea Pharmaceutica International Ltd. | Procedimiento de oxidación para preparar derivados de 3-formil-cefem |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE354577T1 (de) * | 1996-11-06 | 2007-03-15 | Basilea Pharmaceutica Ag | Vinylpyrrolidinon-cephalosporin-derivate |
| TW415949B (en) * | 1996-12-19 | 2000-12-21 | Hoffmann La Roche | Vinyl pyrrolidine cephalosporin derivatives with basic substituents |
-
1999
- 1999-06-07 DE DE69905162T patent/DE69905162T2/de not_active Expired - Lifetime
- 1999-06-07 DK DK99927894T patent/DK1087980T3/da active
- 1999-06-07 HU HU0105426A patent/HUP0105426A3/hu unknown
- 1999-06-07 JP JP2000554745A patent/JP3872955B2/ja not_active Expired - Lifetime
- 1999-06-07 EP EP99927894A patent/EP1087980B1/en not_active Expired - Lifetime
- 1999-06-07 AT AT99927894T patent/ATE231871T1/de active
- 1999-06-07 IL IL13987299A patent/IL139872A0/xx unknown
- 1999-06-07 KR KR10-2000-7014203A patent/KR100411915B1/ko not_active IP Right Cessation
- 1999-06-07 ID IDW20002565A patent/ID27686A/id unknown
- 1999-06-07 BR BRPI9911178A patent/BRPI9911178B8/pt not_active IP Right Cessation
- 1999-06-07 BR BRPI9911178A patent/BRPI9911178C1/pt unknown
- 1999-06-07 WO PCT/EP1999/003907 patent/WO1999065920A1/en active IP Right Grant
- 1999-06-07 CN CNB998073474A patent/CN1136222C/zh not_active Expired - Lifetime
- 1999-06-07 CA CA002334568A patent/CA2334568C/en not_active Expired - Lifetime
- 1999-06-07 PL PL99344994A patent/PL344994A1/xx unknown
- 1999-06-07 AU AU45081/99A patent/AU754732B2/en active Active
- 1999-06-07 ES ES99927894T patent/ES2190222T3/es not_active Expired - Lifetime
- 1999-06-11 AR ARP990102825A patent/AR018675A1/es active IP Right Grant
- 1999-06-11 CO CO99036886A patent/CO5080758A1/es unknown
- 1999-06-11 PE PE1999000521A patent/PE20000645A1/es not_active Application Discontinuation
- 1999-06-14 PA PA19998475701A patent/PA8475701A1/es unknown
- 1999-06-14 GT GT199900084A patent/GT199900084A/es unknown
- 1999-06-15 MA MA25625A patent/MA26650A1/fr unknown
- 1999-06-15 TN TNTNSN99114A patent/TNSN99114A1/fr unknown
- 1999-06-15 SV SV1999000075A patent/SV1999000075A/es not_active Application Discontinuation
-
2000
- 2000-12-13 NO NO20006350A patent/NO20006350L/no not_active Application Discontinuation
-
2014
- 2014-05-15 BE BE2014C034C patent/BE2014C034I2/fr unknown
- 2014-06-11 FR FR14C0044C patent/FR14C0044I2/fr active Active
- 2014-10-01 LU LU92564C patent/LU92564I2/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0111263A (pt) | Derivados de 2-aminocarbonil-9h-purina | |
| BRPI0110955B8 (pt) | derivados de tropano composição farmacêutica, uso dos mesmos na fabricação de um medicamento bem como processo para a preparação dos mesmos. | |
| BRPI0506719A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR0111639A (pt) | Uso de uma molécula de ácido oligodeoxinucléico, e composição farmacêutica contendo a mesma | |
| ECSP034660A (es) | Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen | |
| BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
| ATE427311T1 (de) | (r/s) rifamycin-derivate, ihre herstellung und pharmazeutische zusammensetzungen | |
| BRPI9911178C1 (pt) | derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos | |
| BR9910115A (pt) | Cetolìdeos da classe dos lactamas de 5 elementos | |
| BR9803696A (pt) | Compostos de triazinilaminoestilbeno. | |
| BR0308280A (pt) | Compostos oxo-azabicìclicos | |
| NO167088C (no) | Nye 5-alkoxy-2,4 diaminoalkylbenzener saavel som haarfarvemiddel med 5-alkoxy-2,4-diamino-alkylbenzen. | |
| AR025103A1 (es) | Quelantes quimicos para la reversion del bloqueo neuromuscular inducido por farmacos | |
| WO1999020639A3 (en) | NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES | |
| EA200200232A1 (ru) | Интерлейкин-5 ингибирующие производные 6-азаурацила | |
| PT98473A (pt) | Processo de preparacao de piperazinas 1,4-dissubstituidas e de composicoes farmaceuticas | |
| UA27108A1 (uk) | Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя | |
| BR0008321A (pt) | Secretagogos de hormÈnio de crescimento | |
| BR0115454A (pt) | Composto de 1-metilcarbapenem ou um sal ou derivado de éster deste farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto ou de um sal ou derivado de éster deste farmaceuticamente aceitável | |
| ES2032335T3 (es) | Nuevos derivados flavonoides 2-piperazinil-2-oxo-etilen sustituidos, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen. | |
| ATE447949T1 (de) | Vakuolar-typ (h+)-atpase-hemmende verbindungen, zusammensetzungen und deren verwendungen | |
| BR0113584A (pt) | Derivados de cromanona | |
| ES2131549T3 (es) | Derivados macrolidas de 16 eslabones y su procedimiento de preparacion. | |
| BR9911965A (pt) | Composto, derivado de éster, éter ou n-alquilcarbamoìla farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, processo para o tratamento ou prevenção de uma infecção bacteriana, streptomices griseus, derivado de amida, processo para preparar um composto, e, cepa de streptomyces griseus | |
| EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций |